Nasus Pharma Ltd. (NSRX) — Tangible Net Worth Ratio
Nasus Pharma Ltd. (NSRX) has a Tangible Net Worth Ratio of 100.0% as of December 2025. This metric is calculated by deducting intangible assets ($0.00) from net assets ($2.77 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset momentum of Nasus Pharma Ltd. to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Nasus Pharma Ltd. Tangible Net Worth Ratio (2025–2025)
This chart shows how Nasus Pharma Ltd.'s Tangible Net Worth Ratio has changed across 1 annual periods from 2025 to 2025. As of December 2025, the ratio stands at 100.0%, reflecting net assets of $2.77 Million with intangible assets of $0.00 USD. For live market cap and overall valuation, see market cap of Nasus Pharma Ltd..
Annual Tangible Net Worth Ratio for Nasus Pharma Ltd. (2025–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Nasus Pharma Ltd. from 2025 to 2025, covering 1 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See Nasus Pharma Ltd. free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | $2.77 Million | $0.00 | $5.00 Million | — |